| Name | Title | Contact Details |
|---|
Accelerating progress and time to market of biopharmaceuticals with our integrated CDMO and Testing Service Platform. Global HQ in Philadelphia, PA.
Since 2001, Regent Surgical Health has led the way in developing and managing successful surgery center partnerships. The ASC model is constantly evolving and Regent positions our facility partners to meet these changing market conditions and succeed. Today, a vast majority of our partnerships are Physician/Hospital Joint Ventures. Our experience has led us to develop proprietary ownership models that give both doctors and hospital administrators what they need to ensure long term clinical and financial success. Our success had earned us a reputation as Joint Venture Specialists. Regent has extensive knowledge of the ASC marketplace. We have found successful financial solutions to increase net revenues rather than using out of network strategies, pioneered new procedures such as spine, cardiology, gastric banding, and knee replacements into the ASC environment, and developed both majority and minority hospital partnerships. At Regent, our track record for successful ASC Turnarounds, De Novos, and Joint Ventures is unmatched.
WellDyneRx is a full-service, national pharmacy benefit manager (PBM) that makes the little things matter for our clients, employees, partners, and members.
LXN Corporation is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Vasade Biosciences is a Long Beach Township, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.